AstraZeneca PLC ADR closed 23.70% below its 52-week high of $87.68, which the company reached on August 30th.

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

The partnership, now in its second year, features a limited-edition T-shirt and the Body Check Cup in order to encourage more cancer screenings.

AstraZeneca AZN will report its first-quarter 2025 earnings on April 29, before market open. The Zacks Consensus Estimate for ...

Google DeepMind CEO Demis Hassabis showed 60 Minutes Genie 2, an AI model that generates 3D interactive environments, which ...

Tempus AI reports 30.4% YoY revenue growth in FY2024, driven by genomics and data services. Discover key metrics and ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

AstraZeneca PLC closed 24.38% short of its 52-week high of £133.88, which the company reached on September 3rd.

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...